Aragvadhadi制剂的油和凝胶剂型与Rasayana Churna联合外用治疗白癜风的疗效——一项开放标记的比较临床试验。

Ayu Pub Date : 2021-01-01 Epub Date: 2022-12-07 DOI:10.4103/ayu.AYU_323_20
Sarika Makwana, Dipali Parekh, Prashant Bedarkar, Biswajyoti Patgiri
{"title":"Aragvadhadi制剂的油和凝胶剂型与Rasayana Churna联合外用治疗白癜风的疗效——一项开放标记的比较临床试验。","authors":"Sarika Makwana,&nbsp;Dipali Parekh,&nbsp;Prashant Bedarkar,&nbsp;Biswajyoti Patgiri","doi":"10.4103/ayu.AYU_323_20","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong><i>Aragvadhadi Taila</i> (ART) is one of the herbomineral formulations mentioned in Chakradatta indicated in <i>Shwitra</i> (vitiligo). Modification of <i>Taila</i> form into gel form reduces the risk of contamination in view of arsenical contents (<i>Manahshila</i>, <i>Haratala</i>) assures precise dose administration at desired site (by avoiding spreading). The gel is a comparatively acceptable dosage form than that of medicated oil.</p><p><strong>Aim: </strong>The aim of the study is to evaluate the comparative efficacy of <i>Aragvadhadi</i> formulation in <i>Taila</i> (ART: <i>Aragvadhadi Taila</i>) and gel (ARG: <i>Aragvadhadi</i> gel) dosage forms with the internal administration of <i>Rasayana Churna</i> in the management of <i>Shwitra</i>.</p><p><strong>Materials and methods: </strong>The study was a randomized open labeled, involving 66 patients of <i>Shwitra</i> that were randomly divided into two groups. Patients registered in group A (<i>n</i> = 34) were treated with local applications of ART and group B (<i>n</i> = 32) with ARG for 2 months. <i>Rasayana Churna</i> (3 g), along with the equal quantity of honey and <i>Ghrita</i> was given twice a day after the meal in both groups. Wilcoxon signed-rank test was applied to evaluate the effect of therapy in the individual group for subjective criteria like vitiligo area scoring index score, size and number of patches, <i>Rukshata</i> (dryness), <i>Saparidaha</i> (burning sensation), <i>Bahalatva</i> (thickening), <i>Kandu</i> (itching) while the comparison of results between the groups for the same by applying Coefficient of Variation (CV).</p><p><strong>Results: </strong>Group B showed better and consistent results in all signs and symptoms except <i>Rukshata, Saparidaha</i> in terms of Coefficient of Variation. In both the groups, statistically highly significant improvement was found in signs and symptoms of <i>Shwitra</i> such as <i>Saparidaha, Kandu</i>, size of patches and number of patches; however, the difference between the groups was statistically insignificant.</p><p><strong>Conclusion: </strong>Both the forms (ART, ARG) of <i>Aragvadhadi</i> formulation along with <i>Rasayana Churna</i> were found as a safe and effective treatment in vitiligo with significant pigment regeneration capacity as topical use for application over 2 months.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":"42 1","pages":"19-29"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/78/AYU-42-19.PMC9893897.pdf","citationCount":"0","resultStr":"{\"title\":\"Efficacy of external application of oil and gel dosage forms of <i>Aragvadhadi</i> formulation in combination with <i>Rasayana Churna</i> in the management of <i>Shwitra</i> (vitiligo) - An open-labeled comparative clinical trial.\",\"authors\":\"Sarika Makwana,&nbsp;Dipali Parekh,&nbsp;Prashant Bedarkar,&nbsp;Biswajyoti Patgiri\",\"doi\":\"10.4103/ayu.AYU_323_20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong><i>Aragvadhadi Taila</i> (ART) is one of the herbomineral formulations mentioned in Chakradatta indicated in <i>Shwitra</i> (vitiligo). Modification of <i>Taila</i> form into gel form reduces the risk of contamination in view of arsenical contents (<i>Manahshila</i>, <i>Haratala</i>) assures precise dose administration at desired site (by avoiding spreading). The gel is a comparatively acceptable dosage form than that of medicated oil.</p><p><strong>Aim: </strong>The aim of the study is to evaluate the comparative efficacy of <i>Aragvadhadi</i> formulation in <i>Taila</i> (ART: <i>Aragvadhadi Taila</i>) and gel (ARG: <i>Aragvadhadi</i> gel) dosage forms with the internal administration of <i>Rasayana Churna</i> in the management of <i>Shwitra</i>.</p><p><strong>Materials and methods: </strong>The study was a randomized open labeled, involving 66 patients of <i>Shwitra</i> that were randomly divided into two groups. Patients registered in group A (<i>n</i> = 34) were treated with local applications of ART and group B (<i>n</i> = 32) with ARG for 2 months. <i>Rasayana Churna</i> (3 g), along with the equal quantity of honey and <i>Ghrita</i> was given twice a day after the meal in both groups. Wilcoxon signed-rank test was applied to evaluate the effect of therapy in the individual group for subjective criteria like vitiligo area scoring index score, size and number of patches, <i>Rukshata</i> (dryness), <i>Saparidaha</i> (burning sensation), <i>Bahalatva</i> (thickening), <i>Kandu</i> (itching) while the comparison of results between the groups for the same by applying Coefficient of Variation (CV).</p><p><strong>Results: </strong>Group B showed better and consistent results in all signs and symptoms except <i>Rukshata, Saparidaha</i> in terms of Coefficient of Variation. In both the groups, statistically highly significant improvement was found in signs and symptoms of <i>Shwitra</i> such as <i>Saparidaha, Kandu</i>, size of patches and number of patches; however, the difference between the groups was statistically insignificant.</p><p><strong>Conclusion: </strong>Both the forms (ART, ARG) of <i>Aragvadhadi</i> formulation along with <i>Rasayana Churna</i> were found as a safe and effective treatment in vitiligo with significant pigment regeneration capacity as topical use for application over 2 months.</p>\",\"PeriodicalId\":8720,\"journal\":{\"name\":\"Ayu\",\"volume\":\"42 1\",\"pages\":\"19-29\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/78/AYU-42-19.PMC9893897.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ayu\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ayu.AYU_323_20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/12/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ayu","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ayu.AYU_323_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/12/7 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

简介:Aragvadhadi Taila(ART)是Chakradatta中提到的用于Shwitra(白癜风)的草药制剂之一。鉴于砷含量,将Taila形式改为凝胶形式可降低污染风险(Manahshila,Haratala)确保在所需部位精确给药(避免扩散)。与药物油相比,这种凝胶是一种相对可接受的剂型。目的:本研究的目的是评估泰拉(ART:Aragvadhadi Taila)和凝胶(ARG:Aragvadhadi gel)剂型中的Aragvadadi制剂与Rasayana Churna内部给药在治疗Shwitra中的比较疗效。材料和方法:本研究是一项随机开放标记的研究,涉及66名Shwitra患者,他们被随机分为两组。A组(n=34)登记的患者接受局部应用ART治疗,B组(n=32)接受ARG治疗2个月。Rasayana Churna(3克)以及等量的蜂蜜和Ghrita在两组餐后每天服用两次。Wilcoxon符号秩检验用于评估个体组的治疗效果,主观标准包括白癜风面积评分指数得分、斑块大小和数量、Rukshata(干燥)、Saparidaha(烧灼感)、Baharatva(增厚)、Kandu(瘙痒),同时通过应用变异系数(CV)对各组之间的治疗结果进行比较。结果:在变异系数方面,B组除鲁克沙塔、萨帕力达外的所有体征和症状均表现出较好且一致的结果。在两组中,Shwitra的体征和症状(如Saparidaha、Kandu)、斑块大小和斑块数量均有统计学意义的显著改善;然而,两组之间的差异在统计学上并不显著。结论:两种形式(ART、ARG)的Aragvadhadi制剂与Rasayana Churna一起被发现是一种安全有效的白癜风治疗方法,具有显著的色素再生能力,可局部应用2个月以上。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Efficacy of external application of oil and gel dosage forms of <i>Aragvadhadi</i> formulation in combination with <i>Rasayana Churna</i> in the management of <i>Shwitra</i> (vitiligo) - An open-labeled comparative clinical trial.

Efficacy of external application of oil and gel dosage forms of <i>Aragvadhadi</i> formulation in combination with <i>Rasayana Churna</i> in the management of <i>Shwitra</i> (vitiligo) - An open-labeled comparative clinical trial.

Efficacy of external application of oil and gel dosage forms of <i>Aragvadhadi</i> formulation in combination with <i>Rasayana Churna</i> in the management of <i>Shwitra</i> (vitiligo) - An open-labeled comparative clinical trial.

Efficacy of external application of oil and gel dosage forms of Aragvadhadi formulation in combination with Rasayana Churna in the management of Shwitra (vitiligo) - An open-labeled comparative clinical trial.

Introduction: Aragvadhadi Taila (ART) is one of the herbomineral formulations mentioned in Chakradatta indicated in Shwitra (vitiligo). Modification of Taila form into gel form reduces the risk of contamination in view of arsenical contents (Manahshila, Haratala) assures precise dose administration at desired site (by avoiding spreading). The gel is a comparatively acceptable dosage form than that of medicated oil.

Aim: The aim of the study is to evaluate the comparative efficacy of Aragvadhadi formulation in Taila (ART: Aragvadhadi Taila) and gel (ARG: Aragvadhadi gel) dosage forms with the internal administration of Rasayana Churna in the management of Shwitra.

Materials and methods: The study was a randomized open labeled, involving 66 patients of Shwitra that were randomly divided into two groups. Patients registered in group A (n = 34) were treated with local applications of ART and group B (n = 32) with ARG for 2 months. Rasayana Churna (3 g), along with the equal quantity of honey and Ghrita was given twice a day after the meal in both groups. Wilcoxon signed-rank test was applied to evaluate the effect of therapy in the individual group for subjective criteria like vitiligo area scoring index score, size and number of patches, Rukshata (dryness), Saparidaha (burning sensation), Bahalatva (thickening), Kandu (itching) while the comparison of results between the groups for the same by applying Coefficient of Variation (CV).

Results: Group B showed better and consistent results in all signs and symptoms except Rukshata, Saparidaha in terms of Coefficient of Variation. In both the groups, statistically highly significant improvement was found in signs and symptoms of Shwitra such as Saparidaha, Kandu, size of patches and number of patches; however, the difference between the groups was statistically insignificant.

Conclusion: Both the forms (ART, ARG) of Aragvadhadi formulation along with Rasayana Churna were found as a safe and effective treatment in vitiligo with significant pigment regeneration capacity as topical use for application over 2 months.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ayu
Ayu
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信